QSI · Quantum-Si Inc
Market Cap
$166.57M
Shares
218.88M
QSI metrics
59 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.76
Market cap
$166.57M
Price action
19 metricsPrice change (1W)
-3.7%
Price change (30D)
-0.6%
Price change (3M)
-36.1%
Price change (6M)
-16.4%
Price change (YTD)
-30.8%
Price change (1Y)
-29.5%
Trailing year
Price change (5Y)
-92.3%
52-week high
$2.63
52-week low
$0.70
Change from 52-week high
-71.1%
Change from 52-week low
+8.4%
Annualized volatility
91.8%
Beta
3.7
RSI (14D)
46.0
Price vs SMA 50
-6.4%
Price vs SMA 200
-24.0%
Avg volume (3M)
4.00M
Relative volume
0.4
Average dollar volume
$3.57M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
218.88M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
103.3×
reciprocal yield 1.0%
P / book
0.9
reciprocal yield 108.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-59.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-13
Profitability
9 metricsGross margin
35.0%
Operating margin
-6,887.8%
Trailing 12 months
Net margin
-6,138.3%
Gross profit (TTM)
$562,000
Operating profit (TTM)
−$110.55M
Net income (TTM)
−$98.52M
Trailing 12 months
Diluted EPS (TTM)
$-0.45
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-41.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.60M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+18.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-54.7%
Return on assets
-50.9%
Debt / equity
—
Current ratio
10.0
EBITDA (TTM)
−$105.79M
Free cash flow (TTM)
—
Quick ratio
9.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$23.65M
Total assets
$193.57M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$92.45M
Capital expenditures (TTM)
—
R&D (TTM)
$55.14M
SG&A (TTM)
$40.59M
Stock compensation (TTM)
$11.13M
R&D / revenue
3,435.5%
Stock compensation / revenue
693.5%
Ownership (13F)
3 metrics13F filers
141
13F filer change QoQ
-17
Institutional ownership
24.6%
Short interest
3 metricsShort interest
6.5%
Latest settlement · 4.7 days to cover
Days to cover
4.7d
Short-squeeze score
52 / 100
Insider activity
2 metricsNet insider buying (90D)
−$71,160
Insider-sentiment score
33 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1816431
CUSIP
74765K105
13F (30d)
104 filings
103 filers
Visit website
Investor relations